✦ LIBER ✦

Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist

✍ Scribed by Albert A. Carr; Peter B. Bottini; Peter Feig; L.Michael Prisant; Seamus Mulligan; John G. Devane; Lloyd Fisher; Robert B. Rhoades; E.Paul Mac Carthy

Book ID: 113117871
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 539 KB
Volume: 69
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(92)90015-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Formulation and pharmacokinetic evaluati

Formulation and pharmacokinetic evaluation of once-daily sustained-released system of nifedipine with solid dispersion and coating techniques

✍ Wei, Yu-meng; Xue, Zheng-kai; Wang, Peng; Zhao, Ling 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 396 KB

Effectiveness of the once-daily calcium

Effectiveness of the once-daily calcium antagonist, lacidipine, in controlling 24-hour ambulatory blood pressure

✍ Mary E. Heber; Paul A. Broadhurst; Geoffrey S. Brigden; Edward B. Raftery 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 532 KB

Effect of combination therapy with aroti

Effect of combination therapy with arotinolol and sustained-release nifedipine in patients with essential hypertension resistant to monotherapy

✍ Kazuo Takeda; Tetsuo Nakata; Atsushi Uchida; Hiroshi Fujita; Kazue Nakamura; Tos 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Monotherapy of type 2 diabetes with once

Monotherapy of type 2 diabetes with once-daily gliclazide modified release in primary care

✍ A Ramachandran 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Bioequivalence of a New Sustained-Releas

Bioequivalence of a New Sustained-Release Formulation of Sodium Valproate, Valproate Modified-Release Granules, Compared with Existing Sustained-Release Formulations After Once- or Twice-Daily Administration

✍ Dr. Olivier Dulac; Dr. Jean-Claude Alvarez 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

Antihypertensive effect of once daily su

Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study

✍ F. Arzilli; E. Gandolfi; C. Prato; P. Innocenti; F. Ponzanelli; A. Caiazza; F. G 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 318 KB

To evaluate the magnitude and duration of the antihypertensive effect of sustained release (SRO) isradipine, 37 uncomplicated essential hypertensive patients (diastolic blood pressure 100-115 mm Hg after a one month run-in on placebo) were randomised to receive, according to a double-blind cross-ove